Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
MeSH Number(s)
C18.452.394.750.149
C19.246.300
Concept/Terms
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- NIDDM
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
- Diabetes Mellitus, Noninsulin Dependent
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in Harvard Catalyst Profiles by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 18 | 8 | 26 |
1995 | 22 | 8 | 30 |
1996 | 21 | 11 | 32 |
1997 | 23 | 6 | 29 |
1998 | 34 | 14 | 48 |
1999 | 34 | 11 | 45 |
2000 | 35 | 11 | 46 |
2001 | 41 | 11 | 52 |
2002 | 56 | 25 | 81 |
2003 | 78 | 27 | 105 |
2004 | 87 | 29 | 116 |
2005 | 91 | 29 | 120 |
2006 | 122 | 20 | 142 |
2007 | 146 | 37 | 183 |
2008 | 148 | 38 | 186 |
2009 | 144 | 32 | 176 |
2010 | 177 | 41 | 218 |
2011 | 178 | 49 | 227 |
2012 | 246 | 52 | 298 |
2013 | 227 | 39 | 266 |
2014 | 227 | 56 | 283 |
2015 | 233 | 36 | 269 |
2016 | 251 | 62 | 313 |
2017 | 251 | 52 | 303 |
2018 | 285 | 51 | 336 |
2019 | 330 | 48 | 378 |
2020 | 342 | 46 | 388 |
2021 | 361 | 38 | 399 |
2022 | 438 | 7 | 445 |
2023 | 424 | 4 | 428 |
2024 | 49 | 0 | 49 |
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Postprandial glucose variability and clusters of sex hormones, liver enzymes, and cardiometabolic factors in a South African cohort of African ancestry. BMJ Open Diabetes Res Care. 2024 Mar 07; 12(2).
-
Delivery Device Patents on GLP-1 Receptor Agonists. JAMA. 2024 03 05; 331(9):794-796.
-
Reply: Rethinking eGFR Comparisons in SGLT2 Inhibitor Research. J Am Coll Cardiol. 2024 Mar 05; 83(9):e89.
-
Protective Factors and the Pathogenesis of Complications in Diabetes. Endocr Rev. 2024 Mar 04; 45(2):227-252.
-
Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective database analysis. BMJ Open Diabetes Res Care. 2024 Mar 04; 12(2).
-
Critical Evaluation of Indices Used to Assess ß-Cell Function. Diabetes. 2024 Mar 01; 73(3):391-400.
-
At-home hemoglobin A1c testing during COVID-19 improved glycemic control. Am J Manag Care. 2024 Mar 01; 30(3):e73-e77.
-
Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials. Diabetes Care. 2024 Mar 01; 47(3):501-507.
-
Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes. JAMA Intern Med. 2024 Mar 01; 184(3):265-274.
-
Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes. JAMA. 2024 02 27; 331(8):654-664.